DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Magnevist (Gadopentetate) - Pain - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pain (217)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Magnevist (Gadopentetate) where reactions include pain. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 217   Next >>

Possible Magnevist side effects in 50 year old female

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: 50 year old female, weighing 95.5 kg (210.2 pounds)

Reactions: Pain, Skin Induration, Skin Hyperpigmentation, Nephrogenic Systemic Fibrosis, Rash, Anxiety, Emotional Distress, Anhedonia, Skin Discolouration, Post Thrombotic Syndrome, Skin Mass, Ocular Icterus, Injury, Depression, Mobility Decreased

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Cardiac Imaging Procedure
    Start date: 2003-08-12
    End date: 2003-08-12

Magnevist
    Dosage: unk
    Indication: Renal Scan
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Start date: 2004-02-03
    End date: 2004-02-03

Other drugs received by patient: Clonidine; Sodium Bicarbonate; Calcium Carbonate; Lopressor; Sevelamer Hydrochloride; Atorvastatin; Warfarin Sodium; Rapamune; Epogen; Diltiazem; Benicar



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient: male

Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Anhedonia, Balance Disorder, Skin Lesion, Depression, Mobility Decreased, Extremity Contracture

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2006-11-13

Magnevist

Omniscan

Other drugs received by patient: Hectorol; Coumadin; Metoclopramide; Aspirin; Klor-CON



Possible Magnevist side effects in 47 year old female

Reported by a consumer/non-health professional from United States on 2012-08-17

Patient: 47 year old female

Reactions: Fear of Death, Pain, Fear, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Joint Stiffness, Anxiety, Emotional Distress, Anhedonia, Joint Range of Motion Decreased, Injury, Depression, Nervousness, Scar

Drug(s) suspected as cause:
Magnevist



Possible Magnevist side effects in 61 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: 61 year old male, weighing 124.0 kg (272.8 pounds)

Reactions: Wheelchair User, Pain, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Skin Induration, Paraesthesia, Skin Tightness, Pruritus Generalised, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia, Extremity Contracture, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-01-01
    End date: 2005-01-01

Magnevist
    Dosage: 15 ml (daily dose), once,
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-08-11
    End date: 2000-08-11

Magnevist
    Dosage: 15 ml (daily dose), once,
    Start date: 2001-07-27
    End date: 2001-07-27

Other drugs received by patient: Nephrocaps; Phoslo; Metronidazole; Renagel; Coreg; Prinivil; Atenolol; Warfarin Sodium; Darvocet; Vancocin Hydrochloride; Sodium Bicarbonate; Iron [iron]; Amoxicillin; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Hydrocodone Bitartrate and Acetaminophen; Tylenol with Codein #3; Phoslo; Solivito N [vit C,vit H,b12,b9,b3,pantothenic Ac,b6,b2,b1 Hcl]; Aspirin; Vitamin B6; Coreg; Epogen; Diltiazem; Plendil; Plendil; Lisinopril



Possible Magnevist side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: 58 year old male, weighing 118.0 kg (259.6 pounds)

Reactions: Skin Exfoliation, Quality of Life Decreased, Pain, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Injury, Fibrosis, Blood Creatinine Increased, Extremity Contracture, Blister, Muscle Contracture, Rash Papular, Contrast Media Reaction, Skin Disorder, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Deformity, Skin Tightness, Skin Plaque, Emotional Distress, Anxiety, Burning Sensation, Renal Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist

Other drugs received by patient: Calcium Acetate; Irbesartan; Clonidine; Hydralazine HCL; Visipaque; Visipaque; Glipizide; Ferrous Sulfate TAB; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Metoprolol Tartrate; Sevelamer Hydrochloride; Terazosin Hydrochloride; Dovonex; Contrast Media; Contrast Media; Synthroid; Aspirin; Felodipine; Contrast Media; Lasix; Omniscan; Folic Acid; Iron; Insulin; EPO



Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Indication: Osteomyelitis

Gadolinium IN Unspecified Drug
    Indication: Diabetic Foot

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-05
    End date: 2002-11-05

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-01-14
    End date: 2005-01-14

Magnevist
    Dosage: 15 ml, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Magnevist
    Dosage: unk unk, once
    Start date: 2005-01-25
    End date: 2005-01-25

Magnevist
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-15
    End date: 2002-11-15

Magnevist
    Dosage: 19 ml, once
    Start date: 2004-07-16
    End date: 2004-07-16

Multihance
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Prohance
    Dosage: unk unk, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: male

Reactions: Pain, Abasia, Joint Contracture, Sensory Loss, Skin Hyperpigmentation, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Muscle Contracture, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Grip Strength Decreased, Skin Fibrosis, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-11-13

Gadolinium IN Unspecified Drug
    Indication: Renal Transplant

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Metoclopramide; Klor-CON; Hectorol; Coumadin; Aspirin



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient: male

Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2006-11-13

Magnevist

Omniscan

Other drugs received by patient: Coumadin; Aspirin; Klor-CON; Metoclopramide; Hectorol



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Hyperkeratosis, Pain in Extremity, Bone Pain, Pain, Musculoskeletal Pain, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Hypoaesthesia, DRY Skin, Arthralgia, Oedema, Skin Fibrosis

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-06-06
    End date: 2005-06-06

Gadolinium IN Unspecified Drug
    Indication: Pancreatic Mass

Magnevist

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-05-07
    End date: 2003-05-07

Omniscan
    Dosage: 20 ml (daily dose), once, intravenous
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2002-08-12
    End date: 2002-08-12

Other drugs received by patient: Norvasc; Labetalol HCL; Accupril; Nifedipine; Sensipar; Lisinopril; Dicyclomine; Nitroprusside Sodium; Epoetin NOS; Carvedilol; Hyoscyamine Sulfate; Epogen; Phenytoin; Minoxidil; Sucralfate; Losartan Potassium; Clonidine; Lopressor; Phoslo; Procardia XL; Valtrex; Hydralazine HCL; Coumadin; Renagel; Divalproex Sodium; Nifedipine



Possible Magnevist side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: 50 year old female, weighing 95.5 kg (210.2 pounds)

Reactions: Pain, Skin Induration, Nephrogenic Systemic Fibrosis, Scleroderma, Rash, Skin Hyperpigmentation, Emotional Distress, Anxiety, Skin Discolouration, Skin Mass, Injury, Scleral Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-08-12
    End date: 2003-08-12

Magnevist
    Dosage: unk
    Indication: Cardiac Imaging Procedure
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Indication: Renal Scan
    Start date: 2003-08-07
    End date: 2003-08-07

Magnevist
    Dosage: unk
    Start date: 2004-02-03
    End date: 2004-02-03

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-02-03
    End date: 2004-02-03

Magnevist
    Dosage: unk
    Start date: 2003-08-12
    End date: 2003-08-12

Other drugs received by patient: Warfarin; Lopressor; Sevelamer; Benicar; Atorvastatin; Rapamune; Diltiazem; Calcium Carbonate; Clonidine; Sodium Bicarbonate; Epogen



Possible Magnevist side effects in 49 year old male

Reported by a lawyer from United States on 2012-08-02

Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Start date: 2004-05-19
    End date: 2004-05-19

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-05-19
    End date: 2006-05-19

Magnevist
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-10-13
    End date: 2006-10-13

Magnevist
    Dosage: 20 ml, unk
    Start date: 2006-10-17
    End date: 2006-10-17

Multihance
    Indication: Product Used FOR Unknown Indication

Omniscan

Omniscan
    Dosage: 50 ml omniscan+co2
    Indication: Fistulogram
    Start date: 2006-08-04
    End date: 2006-08-04

Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-05
    End date: 2006-08-05

Optimark
    Indication: Product Used FOR Unknown Indication

Prohance
    Indication: Computerised Tomogram Head
    Start date: 2004-05-19
    End date: 2004-05-19

Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine



Possible Magnevist side effects in male

Reported by a lawyer from United States on 2012-08-01

Patient: male

Reactions: Quality of Life Decreased, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Deformity, Anxiety, Emotional Distress, Fibrosis, Injury, Scar, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Start date: 2004-11-23

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2003-05-10

Omniscan
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-06-25

Omniscan
    Dosage: unk
    Start date: 2004-10-15

Omniscan
    Dosage: unk
    Start date: 2004-10-04

Omniscan
    Dosage: unk
    Start date: 2005-03-18



Possible Magnevist side effects in 39 year old female

Reported by a physician from United States on 2012-08-01

Patient: 39 year old female

Reactions: Pain, Musculoskeletal Discomfort, Skin Hyperpigmentation, Nephrogenic Systemic Fibrosis, Rash, Skin Induration, Skin Plaque, Anxiety, Arthralgia, Fibrosis, Injury

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist



Possible Magnevist side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: female

Reactions: Pruritus, Pain, Joint Contracture, Myosclerosis, Skin Ulcer, Injury, Fibrosis, General Physical Health Deterioration, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Tendon Disorder, Disability

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Omniscan
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram



Possible Magnevist side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: 56 year old female

Reactions: Pruritus, Abasia, Pain, Joint Contracture, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Rash, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Mobility Decreased, Scar

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-05-21
    End date: 2004-05-21

Magnevist
    Indication: Renal Mass

Optimark
    Indication: Muscular Weakness

Optimark
    Indication: Disorientation

Optimark
    Indication: Headache

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Other drugs received by patient: Lantus; Sensipar; Slow Release Iron; Prograf; Phoslo; Renvela; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone; Procrit; Atenolol



Possible Magnevist side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-27

Patient: female

Reactions: Pruritus, Pain, Muscle Contracture, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Skin Ulcer, Arthralgia, Fibrosis, Injury, Disability

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging



Possible Magnevist side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Hyperkeratosis, Pain in Extremity, Pain, Musculoskeletal Pain, Bone Pain, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, DRY Skin, Arthralgia, Oedema, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-05-07
    End date: 2003-05-07

Omniscan
    Dosage: 20 ml (daily dose), once, intravenous
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2002-08-12
    End date: 2002-08-12

Other drugs received by patient: Divalproex Sodium; Coumadin; Sensipar; Lisinopril; Nitroprusside Sodium; Nifedipine; Carvedilol; Sucralfate; Valtrex; Clonidine; Nifedipine; Accupril; Phenytoin; Phoslo; Hyoscyamine Sulfate; Norvasc; Procardia XL; Lopressor; Labetalol HCL; Hydralazine HCL; Epoetin NOS; Dicyclomine; Minoxidil



Possible Magnevist side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: 56 year old female

Reactions: Pruritus, Abasia, Joint Contracture, Pain, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Fibrosis, Injury, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, DRY Skin, Nephrogenic Systemic Fibrosis, Rash, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Scar, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Magnevist
    Indication: Renal Mass

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Muscular Weakness

Optimark
    Indication: Headache

Optimark
    Indication: Disorientation

Other drugs received by patient: Sensipar; Renvela; Prograf; Prednisone; Procrit; Phoslo; Lantus; Slow Release Iron; Atenolol; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]



Possible Magnevist side effects in 79 year old female

Reported by a physician from United States on 2012-07-20

Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Gadolinium Zeolite
    Start date: 2005-08-16
    End date: 2005-08-16

Gadolinium Zeolite
    Start date: 2001-05-03
    End date: 2001-05-03

Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2001-03-05
    End date: 2001-03-05

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Magnevist
    Indication: Angiogram
    Start date: 2001-05-03
    End date: 2001-05-03

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Multihance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Multihance
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: dose reported as eight 20ml vials (160ml)
    Start date: 2005-09-20
    End date: 2005-09-20

Omniscan
    Dosage: route reported as ^first via distal port and then via the proximal port^
    Indication: Angiogram
    Start date: 2003-12-04
    End date: 2003-12-04

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-05-23
    End date: 2003-05-23

Omniscan
    Dosage: dose reported as ^11^ 20ml vials
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-01
    End date: 2005-09-01

Optimark
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2005-08-16
    End date: 2005-08-16

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Prohance
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar



Possible Magnevist side effects in 49 year old female

Reported by a consumer/non-health professional from United States on 2012-07-18

Patient: 49 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Skin Wrinkling, Joint Stiffness, Oedema Peripheral, Melanocytic Naevus, Fibrosis, Arthrofibrosis, General Physical Health Deterioration, Hypoaesthesia, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Paraesthesia, Skin Tightness, Scar, Abasia, Pain, Joint Contracture, Skin Hyperpigmentation, Muscle Tightness, Tendon Pain, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Injury, Joint Ankylosis, Extremity Contracture, Myocardial Fibrosis, Dyspnoea, Rash Papular, Musculoskeletal Pain, Skin Disorder, Muscular Weakness, Rash Macular, Pulmonary Fibrosis, Arthralgia, Gait Disturbance, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Start date: 2004-05-20
    End date: 2004-05-20

Magnevist
    Start date: 1999-11-09
    End date: 1999-11-09

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1997-04-30
    End date: 1997-04-30

Magnevist
    Start date: 1998-12-31
    End date: 1998-12-31

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1996-10-30
    End date: 1996-10-30

Magnevist
    Start date: 2002-01-30
    End date: 2002-01-30

Magnevist
    Start date: 2005-01-30
    End date: 2005-01-30

Magnevist
    Start date: 1997-11-17
    End date: 1997-11-17

Magnevist
    Dosage: 9.7 ml, once
    Start date: 2003-03-20
    End date: 2003-03-20

Magnevist
    Start date: 2000-11-08
    End date: 2000-11-08

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-01-30
    End date: 2005-01-30

Omniscan
    Start date: 2005-03-20
    End date: 2005-03-20

Omniscan
    Dosage: unk

Other drugs received by patient: Thyroid Therapy; Ferrous Sulfate TAB; Miacalcin; Cytoxan; Oxandrin; Folic Acid; Procardia; Synthroid; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Advair Diskus 100 / 50; Zemplar; Aranesp; Aleve; Prograf; Epogen; Exforge; Activase; Celebrex; Zestril; Renagel; Metoprolol Succinate; Amigen; Prempro; Rocaltrol; Spironolactone; Demadex; Sensipar; Myfortic; Prednisone; Clonidine; Amlodipine Besylate



Possible Magnevist side effects in 44 year old female

Reported by a physician from United States on 2012-07-18

Patient: 44 year old female, weighing 130.0 kg (286.0 pounds)

Reactions: Pain, Fear, Scleroderma, Hand Deformity, Skin Discolouration, Oedema, Musculoskeletal Stiffness, Injury, Systemic Sclerosis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Sclerodactylia, Anxiety, Emotional Distress, Arthralgia, Gait Disturbance, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Optimark

Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-02-06

Optimark
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-05-31

Optimark
    Dosage: unk
    Start date: 2005-08-31

Other drugs received by patient: Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Coumadin; Accupril; Atenolol; Epogen; Renagel; Calcitriol; Diovan; Norvasc



Possible Magnevist side effects in 38 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-17

Patient: 38 year old female, weighing 132.0 kg (290.4 pounds)

Reactions: Pain, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Hypertrophy, Joint Stiffness, Anxiety, Emotional Distress, Anhedonia, Arthralgia, Injury, Fibrosis, Asthenia, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2005-01-24
    End date: 2005-01-24

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-07-01
    End date: 2005-07-15

Other drugs received by patient: Hydrochlorothiazide; Topamax; Darvocet; Clonidine; Plaquenil



Possible Magnevist side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12

Patient: 58 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Deformity, Skin Plaque, Skin Tightness, Gait Disturbance, Skin Fibrosis, Mobility Decreased, Scar

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Sensipar; Ativan; Lisinopril; Loperamide; Folic Acid; Tylenol W / Codeine NO. 3; Magnesium Oxide; Plavix; Epogen; Calcijex; Zosyn; Ambien; Vitamin K1; Clonidine; Albumin (Human); Roxanol; Velcade; Adenosine; Aspirin; Dexamethasone; Acetaminophen; Compazine; Dilaudid; Foltx; Diflucan; Vancomycin; Potassium Chloride; Bactrim DS; Ciprofloxacin HCL; Hydroxyzine; Acyclovir; Mucomyst; Biaxin; Metoprolol Tartrate; Atarax; Cyclophosphamide; Norco; Neurontin; Digoxin; Ativan; Prevacid; Dexamethasone; Zoloft; Vitamin K1; Ocean; Senokot; Neupogen; Bicitra; Allopurinol; Pravachol; Levaquin; Phoslo; Gentamicin; Nephrocaps; Adriamycin PFS; Simethicone; Zemplar; Plendil; Midodrine Hydrochloride; Renaphro; Renagel; Ativan; Oxacillin; Etoposide; Reglan; Reglan; Compazine; Warfarin Sodium; Prograf



Possible Magnevist side effects in 51 year old female

Reported by a lawyer from United States on 2012-07-09

Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)

Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-01-11
    End date: 2001-01-11

Magnevist
    Indication: Arteriovenous Fistula Operation
    Start date: 2006-11-28
    End date: 2006-11-28

Magnevist
    Dosage: unk, once
    Indication: Venous Pressure Increased
    Start date: 2004-12-09
    End date: 2004-12-09

Magnevist
    Indication: Dialysis Efficacy Test
    Start date: 2006-09-26
    End date: 2006-09-26

Magnevist
    Indication: Dialysis Device Insertion

Multihance
    Indication: Fistulogram

Multihance
    Indication: Venogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Fistulogram

Omniscan
    Indication: Venogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Venogram

Optimark
    Indication: Fistulogram

Prohance
    Indication: Venogram

Prohance
    Indication: Fistulogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl



Possible Magnevist side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-06

Patient: female

Reactions: Pain, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Fibrosis, Injury, Disability

Drug(s) suspected as cause:
Magnevist
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram



Possible Magnevist side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: 54 year old male

Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-11-29

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-12-12
    End date: 2000-12-12

Magnevist

Omniscan

Optimark

Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec



Possible Magnevist side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: 52 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Pruritus, Pain, Joint Contracture, Anhedonia, Skin Discolouration, Depression, Injury, Extremity Contracture, Peau D'orange, Motor Dysfunction, General Physical Health Deterioration, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, Deformity, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Scar, Skin Fibrosis, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-10-01
    End date: 2005-10-01

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-04-04
    End date: 2006-04-04

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-09-30
    End date: 2005-09-30

Magnevist
    Dosage: unk
    Start date: 2005-10-01
    End date: 2005-10-01

Magnevist
    Dosage: unk
    Start date: 2006-04-04
    End date: 2006-04-04

Other drugs received by patient: Vasotec; Normodyne; Vitamin B-12; Folic Acid; Nephrocaps; Clonidine; Adalat; Amiodarone Hydrochloride; Lopressor; Hydralazine Hydrochloride; Aspirin; Toprol-XL; Lisinopril; Renagel; Epoetin Alfa; Lasix; Cozaar



Possible Magnevist side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-28

Patient: male, weighing 83.0 kg (182.6 pounds)

Reactions: Pruritus, Pain, Quality of Life Decreased, Muscular Weakness, Orthostatic Hypotension, DRY Skin, Stasis Dermatitis, Nephrogenic Systemic Fibrosis, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Mobility Decreased

Drug(s) suspected as cause:
Magnevist

Magnevist
    Indication: Angiogram

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1998-05-18
    End date: 1998-05-18

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Pepcid; Meclizine; Prednisone TAB; Diovan; Plavix; Nexium; Flomax; Warfarin Sodium; Covera-HS; Norvasc; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Coumadin; Epogen; Monopril; Cytoxan; Accupril; Aspirin; Sensipar; Novolin [insulin]; Hydralazine Hydrochloride; Ancef; Acetaminophen; Kayexalate; Humulin [insulin Human Injection, Isophane]; Norvasc; Phoslo; Catapres; Prevacid; Renvela; Lasix; Amiodarone Hydrochloride; Ascorbic Acid; Fish OIL; Sodium Polystyrene Sulfonate; Procrit; Zaroxolyn; Diuril; Darvocet; Neurontin; Renagel; Clonidine; Levothyroxine; Demadex; Potassium Chloride; Verapamil; Percocet; Lopressor; Lipitor



Possible Magnevist side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25

Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Deformity, Skin Plaque, Skin Tightness, Scar, Skin Fibrosis, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Bicitra; Foltx; Plavix; Dexamethasone; Acetaminophen; Adriamycin PFS; Compazine; Dilaudid; Pravachol; Phoslo; Vitamin K1; Etoposide; Reglan; Hydroxyzine; Plendil; Neupogen; Acyclovir; Digoxin; Mucomyst; Renagel; Calcijex; Levaquin; Simethicone; Renaphro; Sensipar; Biaxin; Dexamethasone; Zosyn; Ciprofloxacin; Ocean; Loperamide; Senokot; Clonidine; Albumin (Human); Diflucan; Magnesium Oxide; Potassium Chloride; Gentamicin; Ambien; Compazine; Velcade; Adenosine; Ativan; Lisinopril; Epogen; Oxacillin; Reglan; Zemplar; Roxanol; Allopurinol; Tylenol W / Codeine NO. 3; Ativan; Zoloft; Nephrocaps; Vitamin K1; Cyclophosphamide; Norco; Midodrine Hydrochloride; Warfarin Sodium; Prograf; Folic Acid; Ativan; Aspirin; Prevacid; Metoprolol Tartrate; Vancomycin; Bactrim DS; Atarax; Neurontin



Possible Magnevist side effects in 52 year old female

Reported by a lawyer from United States on 2012-06-22

Patient: 52 year old female

Reactions: Peau D'orange, Pruritus, Pain, Joint Contracture, General Physical Health Deterioration, Skin Disorder, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Anhedonia, Injury, Skin Fibrosis, Scar

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 2006-04-04
    End date: 2006-04-04

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-09-30
    End date: 2005-09-30

Magnevist
    Dosage: unk
    Start date: 2005-10-01
    End date: 2005-10-01

Other drugs received by patient: Adalat; Epoetin Alfa; Folic Acid; Aspirin; Normodyne; Lopressor; Toprol-XL; Lasix; Vasotec; Vitamin B-12



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012